Every SEC Form 3/4/5 on record for this filer (CIK 1759703) — 6 issuers, 33 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| DFTX | Definium Therapeutics, Inc. | Chief Commercial Officer | 2026-02-05 → 2026-06-26 | 3 | −$129,101 |
| BTAI | BioXcel Therapeutics, Inc. | Chief Commercial Officer | 2022-01-19 → 2025-04-01 | 9 | −$6,567 |
| MNMD | Mind Medicine (MindMed) Inc. | Chief Commercial Officer | 2025-03-18 → 2025-03-18 | 2 | — |
| VYNE | VYNE Therapeutics Inc. | Chief Commercial Officer · lapsed | 2020-10-02 → 2021-07-02 | 6 | — |
| MNLO | Menlo Therapeutics Inc. | Chief Commercial Officer · lapsed | 2020-03-11 → 2020-07-02 | 6 | — |
| FOMX | Foamix Pharmaceuticals Ltd. | Chief Commercial Officer · lapsed | 2018-11-26 → 2020-03-11 | 8 | $50,534 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| DFTX | 2026-06-25 | Sell | 2,867 | $45.03 | $129,101 | 174,633 |
| BTAI | 2024-10-03 | Sell | 6,272 | $0.55 | $3,450 | 19,011 |
| BTAI | 2024-09-16 | Sell | 215 | $0.69 | $148 | 4,033 |
| BTAI | 2024-06-17 | Sell | 244 | $1.26 | $307 | 3,498 |
| BTAI | 2024-04-04 | Sell | 1,008 | $2.64 | $2,661 | 2,992 |
3 of 6 issuers are covered and open a security page; the rest are on file here only.